4Sharma V, Sharma S, Hoener zu Bentrup K, et al. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis [ J ]. Nat Struct Biol,2000, 7(8) :663-668.
5McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase[ J]. Nature, 2000, 406:735-738.
10Orozco LC, Quintana FO, Beltran RM, et al. The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis[ J ]. Tubercle, 1986,67(2) :91-97.
7[1]Murray CJL,Lope AD.Global mortality,disability and the contribution of risk factors: global Burden of disease study.Lancet,1997,349(9063): 1436～1442.
8[2]Dye C,Scheele S,Dolin P,et al.Consensus statement global burden of tuberculosis: estimated incidence,prevalence and mortality by country.WHO global surveillance monitoring project.JAMA,1999,282(7): 677～686.
9[3]World Health Organization.World health report 1999.http://www.who.int/whr/1999/en/report.htm/1999.
10[4]Cole ST,Brosch R,Parkhill J,et al.Deciphering the biology of mycobacterium tuberculosis from the complete genome sequence.Nature,1998,393(6685):537～544.
